Brain Mapping Instruments Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

Spread the love

The Brain Mapping Instruments Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Brain Mapping Instruments Market:
https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report

According to The Business Research Company’s Brain Mapping Instruments Global Market Report 2024, The brain mapping instruments market size has grown strongly in recent years. It will grow from $2.13 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the increasing prevalence of neurological disorders, rise in demand for real-time brain monitoring, growth in clinical trials, growth of brain mapping in psychiatry, and expansion of telemedicine.

The brain mapping instruments market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for advanced neuroimaging techniques, growing investments in neuroscience research, increasing adoption of non-invasive brain mapping technologies, growing number of clinical trials, and increasing demand for brain mapping in educational and cognitive development studies. Major trends in the forecast period include technological advancements, integration of virtual reality, personalized medicine, non-invasive brain mapping techniques, and cloud computing

An increase in the prevalence of neurological disorders is expected to propel the growth of the brain mapping instrument market going forward. Neurological disorders are conditions affecting the brain, spinal cord, and nerves, leading to symptoms such as movement issues, cognitive decline, and sensory problems, examples including Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. The increasing prevalence of neurological disorders is due to population aging, urbanization, lifestyle changes, improved diagnostic capabilities, and environmental and infectious risk factors. Brain mapping instruments are essential in clinical practice and research, enabling deeper insights into neurological disorders and guiding personalized treatment strategies. For instance, in March 2021, according to the National Institutes of Health (NIH), a US-based government agency, currently, 6.2 million Americans are living with Alzheimer’s dementia, and this number is projected to increase to 13.8 million by 2060. Therefore, the increase in the prevalence of neurological disorders drives the growth of the brain mapping instrument market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp

The brain mapping instruments market covered in this report is segmented –

1) By Product: Computed Axial Tomography (CAT), Positron Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (fNIRS), Functional Magnetic Resonance Imaging (fMRI), Other Products
2) By Procedure: Devices For Invasive Procedures, Devices For Non-invasive Procedures
3) By End User: Hospitals, Ambulatory Centers

Major companies operating in the brain mapping instrument market are focusing on developing innovative products, such as brain mapping devices, to enhance diagnostic accuracy and treatment efficacy in neurological disorders. Brain mapping devices refer to instruments used to visualize and analyze the structure and function of the brain. These devices employ various techniques such as magnetic resonance imaging (MRI), functional MRI (fMRI), electroencephalography (EEG), magnetoencephalography (MEG), and positron emission tomography (PET). For instance, in August 2022, IBS Hospital, an India-based hospital specializing in Neurology, launched Quicktome, the first brain mapping device. This innovative technology integrates advanced MRI and EEG capabilities with real-time functional imaging, offering unprecedented precision in visualizing brain structure and activity. Its key features include high-resolution imaging for detailed anatomical mapping, simultaneous EEG recording for comprehensive neural activity monitoring, and functional MRI for dynamic brain function analysis.

The brain mapping instruments market report table of contents includes:

1. Executive Summary
2. Brain Mapping Instruments Market Characteristics
3. Brain Mapping Instruments Market Trends And Strategies
4. Brain Mapping Instruments Market – Macro Economic Scenario
5. Global Brain Mapping Instruments Market Size and Growth
.
.
.
32. Global Brain Mapping Instruments Market Competitive Benchmarking
33. Global Brain Mapping Instruments Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Brain Mapping Instruments Market
35. Brain Mapping Instruments Market Future Outlook and Potential Analysis
36. Appendix